| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.86.12.1198 |
| P698 | PubMed publication ID | 10864908 |
| P2093 | author name string | T Takahashi | |
| H Masuda | |||
| J M Isner | |||
| T Asahara | |||
| R Gordon | |||
| S I Hayashi | |||
| A Pieczek | |||
| C Kalka | |||
| H Iwaguro | |||
| E Gravereaux | |||
| O Tepper | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1198-1202 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects | |
| P478 | volume | 86 |
| Q35157591 | A novel oxygen carrier "YQ23" suppresses the liver tumor metastasis by decreasing circulating endothelial progenitor cells and regulatory T cells. |
| Q27025643 | A review of anti-VEGF agents for proliferative diabetic retinopathy |
| Q46779205 | Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4. |
| Q54347900 | Activation of liver X receptor enhances the proliferation and migration of endothelial progenitor cells and promotes vascular repair through PI3K/Akt/eNOS signaling pathway activation. |
| Q45858511 | Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb |
| Q51725956 | Administration of bone marrow cells into surgically induced fibrocollagenous tunnels induces angiogenesis in ischemic rat hindlimb model. |
| Q35962952 | Adult bone marrow-derived hemangioblasts, endothelial cell progenitors, and EPCs |
| Q44013450 | Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization |
| Q33774598 | Allergen-induced, eotaxin-rich, proangiogenic bone marrow progenitors: a blood-borne cellular envoy for lung eosinophilia |
| Q42464955 | Angiogenic activation of valvular endothelial cells in aortic valve stenosis |
| Q40508603 | Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy |
| Q36591067 | Antiangiogenic therapy in human gastrointestinal malignancies |
| Q36820225 | Biologic properties of endothelial progenitor cells and their potential for cell therapy |
| Q35168107 | Biology and flow cytometry of proangiogenic hematopoietic progenitors cells |
| Q90698406 | Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency |
| Q30427978 | Bone marrow-derived progenitor cells augment venous remodeling in a mouse dorsal skinfold chamber model |
| Q38410101 | Breaking the 'harmony' of TNF-α signaling for cancer treatment |
| Q59137719 | CD34 and CD117 Stemness of Lineage-Negative Cells Reverses Memory Loss Induced by Amyloid Beta in Mouse Model |
| Q37967719 | CD34-positive stem cells: in the treatment of heart and vascular disease in human beings |
| Q37463927 | Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma |
| Q26823035 | Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlook |
| Q37000599 | Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. |
| Q41109188 | Circulating endothelial progenitor cells are not affected by acute systemic inflammation |
| Q79272284 | Circulating endothelial progenitor cells are reduced in hemodialysis patients |
| Q73739890 | Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer |
| Q34119449 | Clinical applications of vascular gene therapy |
| Q34017342 | Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction |
| Q36898800 | Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy. |
| Q47141294 | Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application |
| Q35762038 | Endothelial cell proliferation in the choriocapillaris during human retinal differentiation |
| Q42250251 | Endothelial dysfunction in diabetes: potential application of circulating markers as advanced diagnostic and prognostic tools |
| Q38549616 | Endothelial progenitor cells accelerate the resolution of deep vein thrombosis |
| Q37563882 | Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders |
| Q34444790 | Endothelial progenitor cells as factors in neovascularization and endothelial repair |
| Q37815308 | Endothelial progenitor cells as therapeutic agents in the microcirculation: an update |
| Q37061004 | Endothelial progenitor cells for cardiovascular regeneration |
| Q64910765 | Endothelial progenitor cells for postnatal vasculogenesis. |
| Q33572686 | Endothelial progenitor cells in peripheral blood may serve as a biological marker to predict severe acute pancreatitis |
| Q38905378 | Endothelial progenitor cells promote tumor growth and progression by enhancing new vessel formation |
| Q35985560 | Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. |
| Q37325660 | Endothelial progenitor cells: implications for cardiovascular disease |
| Q35985553 | Endothelial progenitor cells: past, state of the art, and future. |
| Q34433667 | Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits |
| Q35150534 | Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? |
| Q37572568 | Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells |
| Q93063997 | Ex vivo expansion of cord blood-derived endothelial cells using a novel xeno-free culture media |
| Q37139734 | Exercise-induced endothelial progenitor cell mobilization is attenuated in impaired glucose tolerance and type 2 diabetes |
| Q35788966 | Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration |
| Q34182635 | FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells |
| Q37284651 | Factors determining heterogeneity in coronary collateral development: A clinical perspective. |
| Q33640562 | Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo |
| Q58087366 | Gene therapy for peripheral arterial disease |
| Q34453212 | Gene therapy in vascular medicine: recent advances and future perspectives |
| Q42415270 | Glucagon-like peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation. |
| Q38928508 | Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus |
| Q38736561 | Growth factors for angiogenesis in peripheral arterial disease. |
| Q28345589 | HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells |
| Q39946864 | HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway |
| Q37276182 | Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen |
| Q36420015 | Hepatic vascular endothelial growth factor regulates recruitment of rat liver sinusoidal endothelial cell progenitor cells |
| Q44610130 | High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage. |
| Q37096297 | Homing and engraftment of progenitor cells: a prerequisite for cell therapy |
| Q47596081 | Hyperglycemia Alters the Protein Levels of Prominin-1 and VEGFA in the Retina of Albino Rats |
| Q33513978 | Identification, isolation and expansion of myoendothelial cells involved in leech muscle regeneration |
| Q34207629 | Immunotherapeutic gene transfer into muscle |
| Q88404860 | Impact of continuous positive airway pressure on vascular endothelial growth factor in patients with obstructive sleep apnea: a meta-analysis |
| Q31037844 | Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment |
| Q39651637 | Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction |
| Q35459633 | Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6) |
| Q35108342 | Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma |
| Q51621553 | Insulin-Like Growth Factor Binding Protein-2 Promotes Adhesion of Endothelial Progenitor Cells to Endothelial Cells via Integrin α5β1. |
| Q83278745 | Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation |
| Q45981429 | Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. |
| Q40089884 | Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes |
| Q90136472 | Mesenchymal Stem Cells Accelerate the Remodeling of Bladder VX2 Tumor Interstitial Microenvironment by TGFβ1-Smad Pathway |
| Q42944903 | Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis |
| Q37866991 | Myeloid cells in cancer progression: unique subtypes and their roles in tumor growth, vascularity, and host immune suppression |
| Q36226806 | Non-viral vectors for gene therapy: clinical trials in cardiovascular disease |
| Q33455791 | Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation |
| Q33649852 | Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. |
| Q37245483 | Obstructive sleep apnea and endothelial progenitor cells |
| Q35225292 | Obstructive sleep apnoea syndrome, endothelial function and markers of endothelialization. Changes after CPAP. |
| Q47664130 | Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation |
| Q30424925 | Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer |
| Q37427910 | Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells |
| Q36839005 | Promise of endothelial progenitor cell for treatment of diabetic retinopathy |
| Q34975463 | Promotion of transplanted bone marrow-derived cell migration into the periodontal tissues due to orthodontic mechanical stress |
| Q35070251 | Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease |
| Q35669620 | Recent concepts for the roles of progenitor/stem cell niche in heart repair. |
| Q37511106 | Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells |
| Q41976719 | Retinal endothelial cell apoptosis stimulates recruitment of endothelial progenitor cells |
| Q36294424 | Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart |
| Q35125820 | Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. |
| Q33509006 | Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model |
| Q33348580 | Stem cell therapy: pieces of the puzzle |
| Q36916458 | Stem cells in sepsis and acute lung injury. |
| Q90457060 | Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization |
| Q43592482 | Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. |
| Q45856327 | Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. |
| Q34475689 | Targeting stem cell niches and trafficking for cardiovascular therapy |
| Q42926963 | The Role of Stem Cells in Wound Angiogenesis |
| Q36174197 | The bone marrow--cardiac axis of myocardial regeneration |
| Q83367859 | The decrement in circulating endothelial progenitor cells (EPCs) in type 2 diabetes is independent of the severity of the hypoadiponectemia |
| Q35921533 | The involvement of endothelial progenitor cells in tumor angiogenesis. |
| Q35052515 | The role of VEGF in normal and neoplastic hematopoiesis |
| Q41242299 | The role of bone marrow-derived endothelial progenitor cells and angiogenic responses in chronic obstructive pulmonary disease |
| Q36275663 | The role of circulating precursors in vascular repair and lesion formation. |
| Q36976439 | Therapeutic myocardial angiogenesis |
| Q35949638 | Therapeutic myocardial angiogenesis with vascular endothelial growth factors |
| Q57767280 | Thérapie génique et cellulaire dans le traitement des pathologies ischémiques des membres inférieurs |
| Q92677843 | Tissue Engineering of the Microvasculature |
| Q34023655 | Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle |
| Q79577457 | Transduction of the anti-apoptotic PTD-FNK protein improves the efficiency of transplantation of bone marrow mononuclear cells |
| Q33293979 | Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). |
| Q35218990 | Transplantation of endothelial progenitor cells for therapeutic neovascularization. |
| Q33624863 | Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy |
| Q42716265 | Tumor necrosis factor-α signaling via TNFR1/p55 is deleterious whereas TNFR2/p75 signaling is protective in adult infarct myocardium |
| Q34154821 | VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. |
| Q42634191 | VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43. |
| Q40631726 | Vascular endothelial growth factor modulates skeletal myoblast function |
| Q26853592 | Vascular endothelial growth factors (VEGFs) and stroke |
| Q34481171 | Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis |
| Q35868133 | Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? |
| Q48278651 | Vascular stem/progenitor cells: functions and signaling pathways. |
| Q83021764 | Vascularization in tissue remodeling after rat hepatic necrosis induced by dimethylnitrosamine |
| Q74601191 | [Growth factors for therapeutic angiogenesis in cardiovascular diseases] |
| Q54640761 | bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells |
Search more.